◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: August 1, 2026
Clindamycin, Adapalene, and Benzoyl Peroxide Gel May Help Acne in Various Age Groups
Researchers studied a gel containing clindamycin, adapalene, and benzoyl peroxide for treating moderate to severe acne in people aged 9 and older. The study found that the gel may be effective in reducing acne lesions in both younger and older participants, regardless of sex. However, more research is needed to confirm these findings.
Why it matters: Understanding how different age groups respond to acne treatments can help dermatologists provide more effective care.
This study pooled data from three clinical trials, but the sample size for older males was relatively small (n=21).
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: July 15, 2026
Tetracycline Use in Japanese Children and Adolescents Studied
Researchers analyzed data on tetracycline use in children and adolescents in Japan from 2015 to 2023. They found that tetracycline use increased, especially among adolescents, and the main reason for use shifted from respiratory infections to acne. The study suggests that treatment patterns for acne may be changing.
Why it matters: This study may help skincare professionals understand how acne treatment patterns are evolving in Japan.
This study analyzed a nationwide administrative claims database, but the underlying clinical indications for tetracycline use remain unclear. The study's findings are based on data from 2015 to 2023, and it is unclear if these trends continue beyond that period.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Skin Barrier DamagePublished: July 10, 2026
Delgocitinib may help treat moderate to severe hand eczema
Researchers studied delgocitinib, a new topical treatment, for its effectiveness in treating moderate to severe hand eczema. They found it to be a potential option with a favorable safety and tolerability profile. However, more data is needed to confirm its long-term use and real-world effectiveness.
Why it matters: This study may help improve understanding of hand eczema treatment options and their potential side effects.
Further data on long-term use and real-world effectiveness are still needed. Delgocitinib was compared to alitretinoin in a single controlled trial.
Animal StudyResults in animals only. May or may not translate to humans.WrinklesPublished: July 4, 2026
Alpha-Ketoglutarate May Help Reduce Skin Damage from UVB Radiation
Researchers studied alpha-ketoglutarate, a compound found in the body, to see if it could help reduce skin damage caused by UVB radiation. They found that it may help restore the skin's natural balance and reduce signs of aging. However, more research is needed to confirm these findings.
Why it matters: This study may help us understand how to prevent or reduce skin damage caused by UVB radiation, which can lead to premature aging and skin cancer.
This study was conducted in a mouse model and used microneedle-assisted transdermal delivery of alpha-ketoglutarate, which may not be the same as topical application in humans. The study's duration was 10 weeks, and more research is needed to confirm these findings in humans.
Animal StudyResults in animals only. May or may not translate to humans.AcnePublished: June 24, 2026
Topical Agents May Help Treat Teat Hyperkeratosis in Dairy Cows
Researchers studied the effectiveness of various topical agents in treating teat hyperkeratosis, a skin condition affecting dairy cows. They found that urea ointment, salicylic acid ointment, and 5% azelaic acid acne cream may help alleviate symptoms. However, the results are based on a small study and more research is needed to confirm these findings.
Why it matters: This study may provide insights into the treatment of skin conditions in animals, which could potentially inform the development of new skincare products or treatments for humans.
This study was conducted on dairy cows and involved a small sample size of 91 animals. The results may not be directly applicable to humans, and more research is needed to confirm the efficacy of these topical agents in treating teat hyperkeratosis.
Animal StudyResults in animals only. May or may not translate to humans.WrinklesPublished: June 15, 2026
Oral ceramide may help reduce UVB-induced skin damage
Researchers studied whether taking oral ceramide could help reduce skin damage caused by UVB radiation. They found that in mice, oral ceramide may help reduce skin pigmentation and improve skin health after exposure to UVB. However, more research is needed to confirm these findings.
Why it matters: This study may help us better understand how to protect skin from UVB damage and potentially develop new treatments for skin disorders.
This study was conducted in mice and may not be directly applicable to humans. The effects of oral ceramide on human skin are unknown.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: June 5, 2026
Isotretinoin Dosing for Acne Varies Widely Among Dermatologists
Researchers studied how dermatologists prescribe isotretinoin for acne and found that dosing varies widely. They looked at data from over 9,500 patients and found that some patients received higher or lower doses than others. The study suggests that there may be room for improvement in prescribing practices.
Why it matters: Understanding isotretinoin dosing variability may help improve acne treatment and ensure equitable care for patients.
This study was a retrospective cohort study, which means it looked back at existing data rather than conducting a new experiment. The study only included patients from Kaiser Permanente Northern California, which may limit its generalizability to other populations.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.WrinklesPublished: June 1, 2026
Understanding Photoaging and Its Treatments
Researchers studied photoaging, a type of skin aging caused by sun exposure, and its effects on skin appearance. They found that chronic sun exposure can lead to wrinkles and pigment changes. The study also looked at how different treatments can help improve photoaged skin.
Why it matters: Understanding photoaging and its treatments may help people take steps to prevent or reduce its effects on their skin.
This review is based on existing research and does not present new findings. The effectiveness of treatments for photoaging may vary depending on individual skin types and conditions.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: June 1, 2026
Combination Treatment May Help Reduce Acne Symptoms
A small study looked at the combination of clascoterone cream and adapalene gel to treat acne. Researchers found that this combination may help reduce acne symptoms, including inflammation and lesion counts, and improve quality of life for patients. However, more research is needed to confirm these findings.
Why it matters: Understanding effective treatments for acne can help individuals manage their symptoms and improve their skin health.
This was a small, open-label pilot study with a short duration (16 weeks) and a small sample size (20 patients).
In VitroCell or tissue culture experiments. No human or animal data.Skin Barrier DamagePublished: May 21, 2026
Konjac Ceramide May Help Reduce Itch in Skin Conditions
Researchers studied how konjac ceramide affects the expression of a protein called semaphorin 3A in human skin cells. They found that konjac ceramide may increase the production of this protein, which could help reduce itch in skin conditions like atopic dermatitis. However, more research is needed to confirm these findings.
Why it matters: This study may help us better understand how to reduce itch in skin conditions, which can be a major issue for people with conditions like atopic dermatitis.
This study was conducted in a lab using human skin cells, so its findings may not directly translate to real-world skin conditions. More research is needed to confirm these results and understand their relevance to human skin health.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: May 20, 2026
Isotretinoin Treatment in Adolescence May Not Affect Adult Height
Researchers studied whether taking isotretinoin for acne during adolescence affects adult height. They analyzed data from over 379,000 individuals in Denmark and found that isotretinoin use was not associated with reduced adult height. However, the study had limitations and more research is needed to confirm these findings.
Why it matters: This study may help inform decisions about isotretinoin treatment for acne in adolescents.
This study was a cross-sectional analysis of existing data and did not directly measure the effects of isotretinoin on growth. The sample size was large, but the study's design and limitations should be considered when interpreting the results.
In VitroCell or tissue culture experiments. No human or animal data.Published: May 12, 2026
Niosomal Cream May Help Improve Tretinoin Stability and Efficacy
Researchers developed a new cream that encapsulates tretinoin, a common skincare ingredient, in tiny particles called niosomes. They tested this cream in lab experiments and found that it may improve tretinoin's stability and effectiveness. However, more research is needed to confirm these results.
Why it matters: This study may help improve our understanding of how to deliver tretinoin more effectively in skincare products.
Lab experiments only, more in vivo and clinical research is needed to validate these results.